Evidence map›Paper›PMID 28242263›Full record

ArticlePreventive medicine2017

Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness.

Randi Melissa Schuster, Madeleine Fontaine, Emily Nip, Haiyue Zhang, Ailish Hanly, A Eden Evins

Abstract read
In one paragraph

Article in Preventive medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Cannabis use, problem-gambling severity, and psychiatric disorders: Data from the National Epidemiological Survey on Alcohol and Related Conditions.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2020
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Randi Melissa SchusterCenter for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: Rschuster@mgh.harvard.edu.
Madeleine FontaineCenter for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Emily NipCenter for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Haiyue ZhangDepartment of Biostatistics, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Ailish HanlyCenter for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; University of Massachusetts Medical School, Worcester, MA, USA.
A Eden EvinsCenter for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Harvard University · USMassachusetts General Hospital · US

Funding

Medical Marijuana, Neurocognition, and Subsequent Substance UseR01DA042043 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI GILMAN, JODI · 2017 to 2021
$3.3M
Mentoring in Addiction Treatment ResearchK24DA030443 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI EVINS, A EDEN · 2010 to 2020
$2.0M
Cognitive Recovery With Cannabis Abstinence Among High School-Aged AdolescentsK23DA042946 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI SCHUSTER, RANDI MELISSA · 2017 to 2021
$1.1M
Neurobehavioral Characterization of Social Influence in Drug AddictionK01DA034093 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI GILMAN, JODI · 2013 to 2017
$925k
NIDA NIH HHS K01 DA034093NIDA NIH HHS K23 DA042946NIDA NIH HHS K24 DA030443NIDA NIH HHS R01 DA042043
6 · The paper itself

Abstract

Young adults with psychiatric illnesses are more likely to use cannabis and experience problems from use. It is not known whether those with a lifetime psychiatric illness experience a prolonged cannabis withdrawal syndrome with abstinence. Participants were fifty young adults, aged 18-25, recruited from the Boston-area in 2015-2016, who used cannabis at least weekly, completed the Structured Clinical Interview for DSM-IV to identify Axis I psychiatric diagnoses (PD+ vs PD-), and attained cannabis abstinence with a four-week contingency management protocol. Withdrawal symptom severity was assessed at baseline and at four weekly abstinent visits using the Cannabis Withdrawal Scale. Cannabis dependence, age of initiation, and rate of abstinence were similar in PD+ and PD- groups. There was a diagnostic group by abstinent week interaction, suggesting a difference in time course for resolution of withdrawal symptoms by group, F(4,46)=3.8, p=0.009, controlling for sex, baseline depressive and anxiety symptoms, and frequency of cannabis use in the prior 90days. In post hoc analyses, there was a difference in time-course of cannabis withdrawal. PD- had significantly reduced withdrawal symptom severity in abstinent week one [t(46)=-2.2, p=0.03], while PD+ did not report improved withdrawal symptoms until the second abstinent week [t(46)=-4.1, p=0.0002]. Cannabis withdrawal symptoms improved over four weeks in young people with and without a lifetime psychiatric diagnosis. However, those with a psychiatric illness reported one week delayed improvement in withdrawal symptom severity. Longer duration of cannabis withdrawal may be a risk factor for cannabis dependence and difficulty quitting.

Indexed as

CannabisBostonFemaleHumansMaleMarijuana AbuseMental DisordersSubstance Withdrawal SyndromeTime FactorsYoung AdultAbstinenceAnxietyCannabisCannabis withdrawal syndromeDepressionMarijuanaMental health

Identifiers

PMID28242263
PMCPMC5572754
OpenAlexW2594766282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.